Stable server-rendered gene record · v1.2.0-measured-dmd-evidence

ZFP69B

Verify expression

G3 · non-DMD perturbation evidenceR1 · non-DMD perturbation substrateSupported · L2 observed same context perturbationAssessed · L2 observed same context perturbation

What this meansZFP69B has been experimentally perturbed in HepG2 cells, but it has not been independently perturbed in a DMD muscle model. Different DMD datasets do not completely agree on its disease-associated direction. The next useful step is verify expression—not a therapeutic claim.

通俗解释ZFP69B已经在HepG2细胞中做过扰动，但尚未在DMD肌肉模型中独立验证。不同DMD数据集对它的疾病相关方向并不完全一致。下一步应完成能弥补当前证据缺口的受控实验，而不能把它直接称为治疗靶点。

Design the next experiment →

Prediction readinessR1 · non-DMD perturbation substrate

Current evidenceObserved perturbation in the same HepG2 context

Additional contextNo qualifying external myogenic screen

Historical DMD prior (legacy)up

Source agreement2/3 sources

Open core JSON Complete typed record Historical detailed audit

Gene Entity Page 2.1 · quantitative layer

Dataset-level evidence for ZFP69B

Every row keeps its original context, metric and denominator. Empty fields remain explicit; no cross-source meta-effect is computed.

Download evidence JSON →

IdentityReleasedHGNC:28053 · ENSG00000187801

PerturbationMeasured in HepG281 contributing cells

Muscle contextScreen not assessed0.15521 TPM in skeletal muscle

DMD context3 source rowsDirectional conflict retained

DMD perturbation truthMissingNo independent DMD-muscle perturbation outcome

Calibrated predictionLockedR1 · no calibrated DMD response model

Dataset-level evidence rows for ZFP69B
Dataset / evidence	Context and endpoint	Observed value	Denominator / support	State and source
HEPG2_CRISPRI_FROZEN_AGGREGATEperturbation observation	Eligible cells contributing to the frozen target-level aggregateHepG2; CRISPRi; non-muscle, non-DMD context	81 cells	81 cells	measuredOpen sourceObserved perturbation coverage in HepG2. The cells are not independent biological replicates and do not establish a DMD effect.
GTEX_V8_SKELETAL_MUSCLEexpression context	Expression feasibility contextHuman skeletal muscle tissue	0.155208 TPM	1 contexts · row count unavailable	context onlyOpen sourceTissue expression supports assay feasibility only; it does not establish cell-type expression, function or perturbation response.
DEPMAP_CONTEXT_METRICdependency context	Median gene-effect context metricDepMap cell-line dependency context; not muscle-specific	-0.107461 DepMap gene-effect score	Denominator not carried	context onlyOpen sourceA broad dependency context metric. It is not a safety result and is not evidence of disease-selective dependency.
HEPG2_CONTEXT_RELATIONSHIP_V06context relationship	Contextual signature relationshipSame processed HepG2 perturbation substrate	0.056341 unitless score	81 cells contributing to the target aggregate	context onlyOpen sourceA descriptive relationship within the same processed context; it is not therapeutic rescue or an independently validated effect.
DMD single-cell baseline pseudobulkdisease context effect	Disease-associated baseline expressionDMD skeletal-muscle single-cell source; baseline pseudobulk summaries	0.40494 source-specific effect scaleMedian signed score 0.00000455	3 contexts · 3 rows0 significant rows	context onlyOpen sourceObserved-expression source summary; contextual evidence rather than candidate perturbation truth.
DMD single-cell delta / DIDdisease context effect	Disease-associated change across declared contextsDMD skeletal-muscle single-cell source; final-label delta / DID summaries	0.025141 source-specific effect scaleMedian signed score 0.00000536	4 contexts · 4 rows0 significant rows	context onlyOpen sourceObserved-expression source summary; contextual evidence rather than candidate perturbation truth.
SEMA3C DESeq2 source-statedisease context effect	Source-specific differential expressionDMD skeletal-muscle source-state analysis	-0.107194 source-specific effect scaleMedian signed score -0.00914757	4 contexts · 4 rows0 significant rows	context onlyOpen sourceObserved-expression source summary; contextual evidence rather than candidate perturbation truth.

Source-specific effect display

DMD source-effect forest

Position is scaled to the largest absolute effect shown for this gene. Values remain on source-specific scales and are not pooled.

sc baseline pseudobulk+0.404943 contexts · 0/3 significant rows

sc delta/DID+0.0251414 contexts · 0/4 significant rows

DESeq2 source-state-0.1071944 contexts · 0/4 significant rows

independent dmd muscle perturbationmissing not negativeUnlock: Run an independent, quality-controlled perturbation in a declared DMD-relevant human myogenic model with biological replication.

per gene deg pathway and cell state profilesource context summary only dmd perturbation missingUnlock: The v1.7 bridge publishes a HepG2 source-context summary and cross-DMD-source pathway projections. A disease-matched candidate perturbation with a biological denominator remains required.

calibrated dmd response predictionlockedUnlock: Accumulate prospective DMD perturbation outcomes and pass the registered calibration, applicability and external-validation gates.

Dataset rows preserve their original context and scale. They are not pooled into a causal effect, therapeutic rank or calibrated DMD prediction.

Frozen candidate bridge · PCB-v0.2-20260804

Cross-context DMD statistical bridge

Measured HepG2 response is compared with three separately measured DMD pathway axes. Individual source results come first; pooled values are exploratory descriptive summaries only.

Download all 21 rows →

Measured candidate DMD perturbations0/21

Validated candidate-level predictions0

Cross-context projection is not a measured ZFP69B response in DMD muscle and does not establish rescue, efficacy, or a target rank.

HepG2 candidate / control cells81 / 4,976Cell-level exploratory comparison; no biological-replicate column.

Target-gene deltaNot measuredTarget absent from the expression panel; missing is not zero.

Exploratory DE rows110 rows at cell-level FDR < 0.05; donor/disease inference blocked.

Robust Reactome pathways00 up · 0 down of 1,378 tested.

Cross-DMD-source pathway projections for ZFP69B
Measured DMD source	Direct projection ρ	Cascade projection ρ	Statistical unit and ceiling
GSE233606	0.015281,360 pathways	-0.013281,360 pathways	one line per condition3566 cells · descriptive unselected gene-axis concordance
GSE272233	0.063091,320 pathways	0.196951,320 pathways	3 reported biological repeats per group21 samples · background-specific correction response
GSE277637	0.229491,360 pathways	0.139151,360 pathways	4 lines with one shared WT10480 cells; 4 pseudobulks · line-specific descriptive effects

Direct projection heterogeneityI² 94.4% · Q 35.69Pooled ρ 0.10406 · source direction consistent

Cascade projection heterogeneityI² 93.8% · Q 32.4Pooled ρ 0.10746 · source direction not consistent

DMD-correction alignmentρ -0.144941,320 pathways · contextual alignment, not candidate validation.

Bridge projection stateABSTAIN OR VALIDATE IN DMD PERTURB SEQL2 CROSS CONTEXT NETWORK HYPOTHESIS ONLY · does not override the governed current action or create a rank.

Why the workflow abstains

weak split half measurement
skeletal muscle tpm le 1
correction alignment not positive
target engagement coordinate missing or not suppressed

Bridge JSON Statistical contract Manifest + SHA-256 ZFP69B evidence TSV

Pathways overlap and the three source vectors are not independent studies. HepG2 cell-level statistics support source-context exploration only. The disease-matched functional-validation gate remains open.

What this candidate is for

Is ZFP69B detectably expressed at RNA and protein level in the intended human muscle model?

A candidate record authorizes a bounded question and next experiment. It does not authorize a therapeutic or clinical claim.

GAP-06

Practical useDecide whether a perturbation experiment would be technically interpretable.

Decision available nowExpression feasibility must be resolved before perturbation resources are committed.

What blocks itExpression feasibility is not verified in the intended model

Minimum next actionMeasure ZFP69B RNA and, where possible, protein in the intended myoblast or myotube state.

How would the result change the decision?

SupportiveMove to a bounded perturbation design if the frozen detectability threshold is met in independent biological replicates.

NullStop or redesign the assay if the target stays below the threshold; this does not establish no biological role.

Inconclusive / QC failureResolve assay specificity or state dependence if RNA, protein or replicates disagree.

Open Study Card Plan the experiment Compare decision gaps

Gene Entity Page 2.1

Entity graph: identity, evidence and prospective objects

This chain shows which objects exist for ZFP69B, which are still drafts and which registries are empty. Empty is not a negative experimental result.

v1.2.0-measured-dmd-evidence

Object IDGENE:v1.2.0-measured-dmd-evidence:ZFP69B

HGNCHGNC:28053

EnsemblENSG00000187801

NCBI Gene65243

Disease scopeDMD evidence context

01 · Gene objectRELEASEDStable identity and typed core record

02 · Evidence objectObserved · context-boundedNo DMD perturbation truth is implied

03 · Model gateR1 · R1 · non-DMD perturbation substratePredictionReadiness governance state

04 · Study objectDRAFT · editableCandidate Study Card available

05 · Prediction objectEMPTYNo immutable prospective prediction

06 · Outcome objectEMPTYNo linked measured outcome

Core JSON Compare evidence Open draft Study Card Prediction registry

Claim boundary: object connectivity improves traceability; it does not raise the evidence tier or authorize a therapeutic claim.

Gene visual profile · 基因证据剖面

One-page evidence profile for ZFP69B

A four-panel, descriptive view of the same bounded gene record: evidence depth, DMD source matrix, context gauges and the current decision gap. No score, target rank or prediction claim is computed.

Evidence profile

L1 resourceStable record released
L2 HepG2 perturbationassessed
L3a external screenNot assessed
L3b independent replicationNot assessed
L4 DMD / muscle validationMissing
L5 therapeutic / clinicalUnsupported

DMD source matrix

sc baseline pseudobulkPositive source directionMedian effect +0.40494 · signed score 0.00000455observed expression · 3 contexts · 0/3 significant rows

sc delta/DIDPositive source directionMedian effect +0.025141 · signed score 0.00000536observed expression · 4 contexts · 0/4 significant rows

DESeq2 source-stateNegative source directionMedian effect -0.107194 · signed score -0.00914757observed expression · 4 contexts · 0/4 significant rows

Observed-expression and regulatory-inference channels are displayed side by side and are not pooled as independent cohorts.

Context gauges

Source agreement2/3 sources

This measures agreement among source pipelines; it is not biological ground truth.

Muscle expression0.155 TPM

Visual guide; ≥1 TPM is the current triage threshold.

Cells contributing to the aggregate81

Coverage count, not a power calculation.

External screenNot assessed

No qualifying evidence is available in this release; this is not a negative result.

Gap ladder

GAP-06Expression feasibility is not verified in the intended model

Current actionVerify expression
Highest missing layerL4 dmd functional validation
Claim boundaryNo P1/P2 prediction claim unlocked

Interpretation boundary: this visual profile reorganizes frozen fields for inspection. It does not create a source-balanced successor result, a causal conclusion, a therapeutic direction or a clinical decision-support claim.

Decision boundary

What must be resolved next

Decision-blocking gapGAP-06 · Expression feasibility is not verified in the intended model

Highest missing layerL4 dmd functional validation

Readiness upgrade requiredAdd a muscle-context or DMD-background perturbation endpoint with frozen analysis rules.

The decision-blocking gap is the next missing layer that prevents the current action from advancing. The highest missing layer is the longer-term evidence ceiling; it is not necessarily the next experiment.

DMD context

Source-state record

DMD source-state fields for ZFP69B
Direction state	conflicted
Variant stability	sign varied across variants
Evidence modules	direction conflicted
Statistical support	direction only no significant context rows
Coverage	3 of 4 sources
Uncertainty	direction conflict retained

Identifiers and context

Machine-resolvable core

Machine-resolvable identifiers and context for ZFP69B
HGNC	HGNC:28053
Ensembl	ENSG00000187801
NCBI Gene	65243
HepG2 perturbation	assessed
HepG2 observed cells	81
Observed counteralignment	0.05634125
Myoblast screen	not assessed
Myoblast fusion-screen effect	Not available
Myoblast fusion-screen FDR	Not available
Skeletal-muscle expression	0.155208 TPM
DepMap median gene effect	-0.10746111

Cite this record

Stable identity

Object ID: GENE:v1.2.0-measured-dmd-evidence:ZFP69B

NMD-VCell. ZFP69B evidence record. Resource v1.2.0-measured-dmd-evidence; evidence freeze 2026-08-03; schema 1.1; build EA-20260817-57. DOI pending.

Schema 1.1 · evidence freeze 2026-08-03 · build EA-20260817-57 · one of 17,921 stable core records.